检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:潘骋 俞军[2] PAN Cheng;YU Jun(Department of General Surgery,the 903rd Hospital of the Joint Logistics Support Force of the People's Liberation Army of China,Hangzhou Zhejiang 310000,China;Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou Zhejiang 310000,China)
机构地区:[1]中国人民解放军联勤保障部队第九〇三医院普通外科,浙江杭州310000 [2]浙江大学医学院附属第一医院肝胆胰外科,浙江杭州310000
出 处:《中国卫生标准管理》2024年第12期195-198,共4页China Health Standard Management
摘 要:脾脏原发性血管肉瘤作为一种罕见的恶性肿瘤,在诊断治疗等方面均尚处于研究阶段。脾脏原发性血管肉瘤的病理机制十分复杂,如肿瘤放化疗、毒物质等均是其影响因素。且脾脏原发性血管肉瘤治疗预后效果极差,手术加放化疗辅助,患者平均生存期不足6个月,且相关治疗方案尚未形成标准化,探索性研究仍是当前对于脾脏原发性血管肉瘤治疗的现状。文章从脾脏原发性血管肉瘤的临床研究出发,以脾脏原发性血管肉瘤、病理、诊断、治疗、进展等为关键词,基于万方、知网、维普等搜索平台,围绕脾脏原发性血管肉瘤的临床病理、治疗方法2个方面就国内外相关研究报道进行文献综述研究,旨在为脾脏原发性血管肉瘤的病理特征研究、临床治疗创新提供更加完备的参考资料。Primary vascular sarcoma of the spleen,as a rare malignant tumor,is still in the research stage in terms of diagnosis and treatment.The pathological mechanism of primary splenic angiosarcoma is very complex,such as tumor radiotherapy and chemotherapy,toxic substances,etc.,which are all influencing factors.Moreover,the prognosis for the treatment of primary splenic angiosarcoma is extremely poor,with surgery combined with radiotherapy and chemotherapy.The average survival time of patients is less than 6 months,and the relevant treatment plans have not yet formed standardization.Exploratory research is still the current situation for the treatment of primary splenic angiosarcoma.Starting from the clinical research of primary splenic vascular sarcoma,this article takes the keywords of primary splenic vascular sarcoma,pathology,diagnosis,treatment,progress,etc.,based on search platforms such as Wanfang,CNKI,and VIP,and focuses on the clinical pathology and treatment methods of primary splenic vascular sarcoma.A literature review is conducted on relevant research reports at home and abroad,aiming to provide more comprehensive reference materials for the pathological characteristics research and clinical treatment innovation of primary splenic vascular sarcoma.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.49